The forecast for leukemia mortality among females in the UK shows a stabilization in the number of deaths from 2024 to 2026, maintaining a consistent value of 1.96 thousand. There is a slight increase to 1.97 thousand in 2027 and 2028. As of 2023, the value stood at 1.95 thousand female deaths. Year-on-year variation is negligible, less than 1% over the last two years, with a similar pattern expected over the next five years. The compound annual growth rate (CAGR) over the last five years indicates near-zero growth, reflecting stability in mortality rates.

Future trends to watch for:

Advancements in treatments and early diagnosis methods that could potentially lower mortality rates.
The impact of healthcare policies and funding on leukemia research and patient care.
The role of emerging technologies and personalized medicine in improving patient outcomes.